Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Michael Bradshaw
Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Activation Mechanism and Steady State Kinetics of Bruton's Tyrosine Kinase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Related publications
Inducible T Cell Kinase (ITK); IL-2
Science-Business eXchange
SRC-Induced Activation of Inducible T Cell Kinase (ITK) Requires Phosphatidylinositol 3-Kinase Activity and the Pleckstrin Homology Domain of Inducible T Cell Kinase
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A Phase 1/1b Dose-Escalation Trial Evaluating Cpi-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, in Patients With Relapsed/Refractory T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Identification of Rlk, a Novel Protein Tyrosine Kinase With Predominant Expression in the T Cell Lineage
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Monochloramine Inhibits Phorbol Ester-Inducible Neutrophil Respiratory Burst Activation and T Cell Interleukin-2 Receptor Expression by Inhibiting Inducible Protein Kinase C Activity
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34
Angewandte Chemie
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent and Selective Covalent Inhibitor of Brutons Tyrosine Kinase
Targeting Tumour Microenvironment by Tyrosine Kinase Inhibitor
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Interleukin-2 Triggers a Novel Phosphatidylinositol 3-Kinase-Dependent MEK Activation Pathway.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
